Viral Genetics Inc. (VRAL)'s Lead Scientist Dr. M. Karen Newell Will Present at 11th Annual SoCalBio Investor and Partnership Conference
9/17/2009 10:48:12 AM
More...
|
Viral Genetics Inc. (VRAL) Completes Second Major Debt Conversion
8/27/2009 8:23:46 AM
More...
|
Viral Genetics Inc. (VRAL) Responds to Rumors of Imminent FDA Filing and Third Party Press Releases
8/27/2009 8:18:16 AM
More...
|
Viral Genetics Inc. (VRAL) Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium
8/12/2009 8:32:46 AM
More...
|
Viral Genetics Inc. (VRAL) Creates Subsidiary to Develop Cancer Therapy
8/7/2009 6:30:31 AM
More...
|
Viral Genetics Inc. (VRAL) Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances
7/13/2009 8:49:54 AM
More...
|
Viral Genetics Inc. (VRAL) Pursues Promising New Therapy for Lyme Disease With Grant from Time for Lyme, Inc.
5/21/2009 11:16:15 AM
More...
|
Viral Genetics Inc. (VRAL) Pursues Promising New Therapy for Lyme Disease With Grant from Time for Lyme, Inc.
4/16/2009 11:06:38 AM
More...
|
Viral Genetics Inc. (VRAL) Successfully Secures Grant for New Lyme Research Study
3/18/2009 11:41:20 AM
More...
|
Dr. Leslie Z. Benet, An Internationally Recognized Expert in Drug Development, Has Joined Advisors at Viral Genetics Inc. (VRAL)
1/21/2009 8:56:42 AM
More...
|
|